PE20080364A1 - Acido bifenilcarboxilicos substituidos y sus derivados como moduladores de la actividad de la gamma-secretasa - Google Patents
Acido bifenilcarboxilicos substituidos y sus derivados como moduladores de la actividad de la gamma-secretasaInfo
- Publication number
- PE20080364A1 PE20080364A1 PE2007000496A PE2007000496A PE20080364A1 PE 20080364 A1 PE20080364 A1 PE 20080364A1 PE 2007000496 A PE2007000496 A PE 2007000496A PE 2007000496 A PE2007000496 A PE 2007000496A PE 20080364 A1 PE20080364 A1 PE 20080364A1
- Authority
- PE
- Peru
- Prior art keywords
- substituted
- modulators
- gamma
- acid
- secretase
- Prior art date
Links
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 title abstract 2
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 150000001875 compounds Chemical group 0.000 abstract 2
- QDKWLJJOYIFEBS-UHFFFAOYSA-N 1-fluoro-4-$l^{1}-oxidanylbenzene Chemical class [O]C1=CC=C(F)C=C1 QDKWLJJOYIFEBS-UHFFFAOYSA-N 0.000 abstract 1
- RFONJRMUUALMBA-UHFFFAOYSA-N 2-methanidylpropane Chemical compound CC(C)[CH2-] RFONJRMUUALMBA-UHFFFAOYSA-N 0.000 abstract 1
- -1 BIPHENYL CARBOXYL Chemical class 0.000 abstract 1
- 235000010290 biphenyl Nutrition 0.000 abstract 1
- 239000004305 biphenyl Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical class O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 abstract 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 1
- 150000003536 tetrazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
SE REFIERE A COMPUESTOS ACIDO BIFENILCARBOXILICOS SUBSTITUIDOS DE FORMULA (I), EN DONDE A ES O, NH U S; X ES -CR5R6, DONDE R5 Y R6 SON INDEPENDIENTEMENTE H, ALQUILO SELECCIONADO DE CH3, C2H5, i-C4H9, ENTRE OTROS; R1, R2, R3 Y R4 SON INDEPENDIENTEMENTE H, HALOGENO, OH, ALQUILO OPCIONALMENTE SUSTITUIDO, ENTRE OTROS; R9 Y R10 SON INDEPENDIENTEMENTE H, F O CF3; Y ES UN GRUPO CARBOXI-C(O)OH O UN TETRAZOL SUSTITUIDO O NO. SON SELECCIONADOS: ACIDO 2-(5-(4-FLUOROFENOXI)-4'-TRIFLUOROMETILBIFENIL-3-IL)-PENTANOICO, ACIDO 2-(5-(FENOXI)-4'-TRIFLUOROMETILBIFENIL-3-IL)-PENTANOICO, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON MODULADORES DE LA ACTIVIDAD DE LA GAMMA-SECRETASA POR LO QUE SON UTILES EN EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER (EA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06112938A EP1849762B1 (en) | 2006-04-21 | 2006-04-21 | Substituted biphenyl carboxylic acids and derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080364A1 true PE20080364A1 (es) | 2008-05-16 |
Family
ID=36688012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000496A PE20080364A1 (es) | 2006-04-21 | 2007-04-20 | Acido bifenilcarboxilicos substituidos y sus derivados como moduladores de la actividad de la gamma-secretasa |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US7557244B2 (es) |
| EP (2) | EP1849762B1 (es) |
| JP (1) | JP5479088B2 (es) |
| KR (1) | KR101542255B1 (es) |
| CN (1) | CN101687758B (es) |
| AP (1) | AP2008004656A0 (es) |
| AR (1) | AR060568A1 (es) |
| AU (1) | AU2007240335B2 (es) |
| BR (1) | BRPI0710656A2 (es) |
| CA (1) | CA2650006C (es) |
| CR (2) | CR10375A (es) |
| CY (1) | CY1109399T1 (es) |
| DE (1) | DE602006007810D1 (es) |
| DK (1) | DK1849762T3 (es) |
| EA (1) | EA016129B9 (es) |
| ES (2) | ES2328616T3 (es) |
| GE (1) | GEP20115269B (es) |
| GT (1) | GT200900120A (es) |
| IL (2) | IL194790A (es) |
| MA (1) | MA30475B1 (es) |
| MX (1) | MX2008013445A (es) |
| MY (1) | MY148953A (es) |
| NO (1) | NO20084517L (es) |
| NZ (1) | NZ573000A (es) |
| PE (1) | PE20080364A1 (es) |
| PL (1) | PL1849762T3 (es) |
| PT (1) | PT1849762E (es) |
| SI (1) | SI1849762T1 (es) |
| SM (1) | SMP200800061B (es) |
| TN (1) | TNSN08413A1 (es) |
| TW (1) | TWI399362B (es) |
| UA (1) | UA95952C2 (es) |
| UY (1) | UY30301A1 (es) |
| WO (1) | WO2007124394A1 (es) |
| ZA (1) | ZA200809856B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8692017B2 (en) | 2007-10-19 | 2014-04-08 | Janssen Pharmaceutica, N.V. | Carbon linked modulators of gamma-secretase |
| EP2212277B1 (en) * | 2007-10-19 | 2016-08-31 | Janssen Pharmaceutica, N.V. | Amine linked modulators of y-secretase |
| BRPI0817433A2 (pt) | 2007-10-19 | 2015-06-16 | Janssen Pharmaceutica Nv | Moduladores de gama-secretase piperidinila e piperazinila |
| CA2702911A1 (en) * | 2007-10-19 | 2009-04-23 | Chih Yung Ho | Gsm intermediates |
| WO2009067493A2 (en) * | 2007-11-19 | 2009-05-28 | Envivo Pharmaceuticals, Inc. | 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders |
| RU2527177C2 (ru) | 2007-12-20 | 2014-08-27 | Энвиво Фармасьютикалз, Инк. | Четырехзамещенные бензолы |
| EP2488031A4 (en) * | 2009-10-16 | 2014-07-23 | Merck Sharp & Dohme | DIARYL ETHER DERIVATIVES AS A NOTCH-PROOFING GAMMETRETASE INHIBITOR |
| US8785481B2 (en) | 2010-09-29 | 2014-07-22 | Merck Sharp & Dohme Corp. | Ether benzotriazole derivatives |
| WO2012119035A1 (en) * | 2011-03-03 | 2012-09-07 | Treventis Corporation | Anti-amyloid compounds and methods |
| WO2015109109A1 (en) | 2014-01-15 | 2015-07-23 | Forum Pharmaceuticals Inc. | Fused morpholinopyrimidines and methods of use thereof |
| US9802927B2 (en) | 2015-06-10 | 2017-10-31 | Denali Therapeutics, Inc. | Oxadiazine compounds and methods of use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5877399A (en) * | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
| JP3802581B2 (ja) * | 1995-03-01 | 2006-07-26 | 富山化学工業株式会社 | 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤 |
| WO2001078721A1 (en) | 2000-04-13 | 2001-10-25 | Mayo Foundation For Medical Education And Research | Aβ42 LOWERING AGENTS |
| DE10131899A1 (de) | 2001-07-04 | 2003-02-27 | Boehringer Ingelheim Pharma | In vitro-Screening-Assay für gamma-Secretase |
| KR100693367B1 (ko) * | 2002-06-27 | 2007-03-12 | 아스텔라스세이야쿠 가부시키가이샤 | 아미노알콜 유도체 |
| GB0305918D0 (en) * | 2003-03-14 | 2003-04-23 | Glaxo Group Ltd | Novel compounds |
| WO2005110963A1 (en) * | 2004-05-19 | 2005-11-24 | Cellzome Ag | (biphenyl-3-yl)-carboxylic acids and derivatives thereof and their use in therapy |
| GB0416508D0 (en) * | 2004-07-23 | 2004-08-25 | Merck Sharp & Dohme | Therapeutic agents |
| TW200621227A (en) * | 2004-08-24 | 2006-07-01 | Kissei Pharmaceutical | Medicament for preventing or treating fatty liver |
| US8148572B2 (en) * | 2005-10-06 | 2012-04-03 | Astrazeneca Ab | Compounds |
-
2006
- 2006-04-21 PT PT06112938T patent/PT1849762E/pt unknown
- 2006-04-21 EP EP06112938A patent/EP1849762B1/en not_active Not-in-force
- 2006-04-21 SI SI200630391T patent/SI1849762T1/sl unknown
- 2006-04-21 PL PL06112938T patent/PL1849762T3/pl unknown
- 2006-04-21 DK DK06112938T patent/DK1849762T3/da active
- 2006-04-21 ES ES06112938T patent/ES2328616T3/es active Active
- 2006-04-21 DE DE602006007810T patent/DE602006007810D1/de active Active
-
2007
- 2007-04-20 ES ES07760976T patent/ES2400530T3/es active Active
- 2007-04-20 MY MYPI20084201A patent/MY148953A/en unknown
- 2007-04-20 MX MX2008013445A patent/MX2008013445A/es active IP Right Grant
- 2007-04-20 GE GEAP200710983A patent/GEP20115269B/en unknown
- 2007-04-20 AP AP2008004656A patent/AP2008004656A0/xx unknown
- 2007-04-20 NZ NZ573000A patent/NZ573000A/en not_active IP Right Cessation
- 2007-04-20 US US11/737,938 patent/US7557244B2/en not_active Expired - Fee Related
- 2007-04-20 UA UAA200813476A patent/UA95952C2/ru unknown
- 2007-04-20 CN CN200780018586.2A patent/CN101687758B/zh not_active Expired - Fee Related
- 2007-04-20 BR BRPI0710656-4A patent/BRPI0710656A2/pt not_active IP Right Cessation
- 2007-04-20 KR KR1020087028566A patent/KR101542255B1/ko not_active Expired - Fee Related
- 2007-04-20 EA EA200802172A patent/EA016129B9/ru not_active IP Right Cessation
- 2007-04-20 JP JP2009506782A patent/JP5479088B2/ja not_active Expired - Fee Related
- 2007-04-20 EP EP07760976A patent/EP2021314B1/en active Active
- 2007-04-20 UY UY30301A patent/UY30301A1/es unknown
- 2007-04-20 WO PCT/US2007/067039 patent/WO2007124394A1/en not_active Ceased
- 2007-04-20 AR ARP070101725A patent/AR060568A1/es not_active Application Discontinuation
- 2007-04-20 PE PE2007000496A patent/PE20080364A1/es active IP Right Grant
- 2007-04-20 AU AU2007240335A patent/AU2007240335B2/en not_active Ceased
- 2007-04-20 CA CA2650006A patent/CA2650006C/en not_active Expired - Fee Related
- 2007-04-20 SM SM200800061T patent/SMP200800061B/it unknown
- 2007-04-20 TW TW096114160A patent/TWI399362B/zh not_active IP Right Cessation
-
2008
- 2008-10-17 CR CR10375A patent/CR10375A/es not_active Application Discontinuation
- 2008-10-17 TN TNP2008000413A patent/TNSN08413A1/en unknown
- 2008-10-22 IL IL194790A patent/IL194790A/en not_active IP Right Cessation
- 2008-10-22 IL IL194852A patent/IL194852A0/en unknown
- 2008-10-27 NO NO20084517A patent/NO20084517L/no not_active Application Discontinuation
- 2008-11-19 ZA ZA200809856A patent/ZA200809856B/xx unknown
- 2008-11-20 MA MA31395A patent/MA30475B1/fr unknown
- 2008-11-21 CR CR10451A patent/CR10451A/es not_active Application Discontinuation
-
2009
- 2009-05-11 GT GT200900120A patent/GT200900120A/es unknown
- 2009-09-21 CY CY20091100982T patent/CY1109399T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080364A1 (es) | Acido bifenilcarboxilicos substituidos y sus derivados como moduladores de la actividad de la gamma-secretasa | |
| PE20080267A1 (es) | Compuestos triarilicos y sus derivados | |
| PE20050948A1 (es) | Compuestos de carbamoil-amina como inhibidores de la dipeptidil peptidasa iv | |
| PE20081135A1 (es) | Derivados que contienen sulfamoilo y sus usos | |
| PE20060777A1 (es) | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas | |
| PE20121640A1 (es) | Derivados de pirazina como inhibidores de bace | |
| PE20080951A1 (es) | DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS | |
| PE20091466A1 (es) | Derivados de 4,5-dihidro-oxazol-2-il-amina | |
| PE20081545A1 (es) | Derivados de sulfonamida como inhibidores de acido graso sintasas | |
| PE20090601A1 (es) | Derivados de piridin-il-oxi-piridinas como inhibidores de alk5 | |
| PE20061303A1 (es) | Composicion farmaceutica que comprende oxaprozina | |
| PE20130311A1 (es) | Composiciones y metodos para modular la via de senalizacion de wnt | |
| PE20090840A1 (es) | Moleculas pequenas que contienen boro | |
| PE20140191A1 (es) | Moduladores de receptores de estrogenos y usos de los mismos | |
| EA201390222A1 (ru) | Гетероциклическое соединение и его применение | |
| PE20080359A1 (es) | Compuestos de benzoxazol y benzotiazol 6-0-sustituidos y metodos de inhibicion de la senalizacion de csf-1r | |
| PE20091828A1 (es) | Derivados de acido ciclopentanocarboxilico condensados sustituidos con acilamino como inhibidores de edg-2 | |
| PE20081475A1 (es) | Arilamidas sustituidas por tiazol u oxazol | |
| EA201001733A1 (ru) | Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк) | |
| PE20142282A1 (es) | Nuevos derivados de aril-quinolina | |
| PE20060298A1 (es) | Derivados de acido carboxilico de bencimidazolona | |
| AR077227A1 (es) | Compuesto de acido aril/ heteroaril- sustituido carboxilico, su uso para fabricar un medicamento util el tratamiento de afecciones o trastornos mediados por receptores s1p1, tales como esclerosis multiple y composicion farmaceutica que lo comprende | |
| GB0517191D0 (en) | Compounds | |
| IL183373A0 (en) | 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| PE20091649A1 (es) | Derivados de pirrolidinilo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |